6095 POSTER Randomized, Open-label, Phase 3 Study of Panitumumab (Pmab) With FOLFOX4 Vs FOLFOX4 Alone as 1st-line Treatment for Metastatic Colorectal Cancer (mCRC) – the Role of Hypomagnesemia (Hypomag) on Efficacy

Saved in:
Bibliographic Details
Title: 6095 POSTER Randomized, Open-label, Phase 3 Study of Panitumumab (Pmab) With FOLFOX4 Vs FOLFOX4 Alone as 1st-line Treatment for Metastatic Colorectal Cancer (mCRC) – the Role of Hypomagnesemia (Hypomag) on Efficacy
Authors: Burkes, R., Siena, S., Cassidy, J., Tabernero, J., Barugel, M.E., Humblet, Y., Cunningham, D., Xu, F., Krishnan, K., Douillard, J.Y.
Source: European Journal of Cancer. Sep2011 Supplement 1, Vol. 47, pS420-S420. 1p.
Database: Academic Search Ultimate
Description
ISSN:09598049
DOI:10.1016/S0959-8049(11)71740-3